THE ACTIVATION OF PROTO-ONCOGENE C-HA-RAS ANDTHE CONTROL OF ITS EXPRESSION IN HUMANSTOMACH CANCER

被引:0
|
作者
邓国仁
Wu
武纯静
苗晶
李华
徐宁志
金晓明
鄂征
机构
关键词
THE ACTIVATION OF PROTO-ONCOGENE C-HA-RAS ANDTHE CONTROL OF ITS EXPRESSION IN HUMANSTOMACH CANCER; DNA;
D O I
暂无
中图分类号
学科分类号
摘要
Activated oncogene c-Ha-ras in stomach cancer tissues was identified by DNA transfection. The point mutations were determined in five DNA samples (from three solid tumors of patients with gastro-carcinoma and two cell lines) out of twelve (eight solid tumors and four cell lines) by the restriction fragment length polymorphysm (RFLP) assay. The expressions of c-Ha-ras were enhanced to higher levels (10-20 times) in two cell lines. The lengths of variable tandem repetition (VTR) sequences downstream from the c-Ha-ras coding region were compared for different DNA samples. Their ability to enhance c-Ha-ras expression and their transforming ability are discussed.
引用
收藏
页码:5 / 8
页数:4
相关论文
共 50 条
  • [21] Differential expression and characterization of proto-oncogene product Ha-Ras GTPase in camel tissues
    NurEKamal, MSA
    Raza, H
    Qureshi, MM
    Jaffer, U
    Ijaz, MK
    INTERNATIONAL JOURNAL OF ONCOLOGY, 1997, 11 (01) : 47 - 52
  • [22] ACTIVATION OF THE C-HA-RAS-1 PROTO-ONCOGENE BY METHYLATION INVITRO WITH ALPHA-ACETOXY-N-NITROSODIMETHYLAMINE
    HIRANIHOJATTI, S
    MILLIGAN, JR
    KOVNAT, A
    BROWN, K
    ARCHER, MC
    MOLECULAR CARCINOGENESIS, 1989, 2 (02) : 101 - 106
  • [23] REPLICATION BLOCKS AND SEQUENCE INTERACTION SPECIFICITIES IN THE CODON-12 REGION OF THE C-HA-RAS PROTO-ONCOGENE INDUCED BY 4 CARCINOGENS INVITRO
    MARIEN, K
    MATHEWS, K
    VANHOLDE, K
    BAILEY, G
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1989, 264 (22) : 13226 - 13232
  • [24] REGULATION OF C-MYC AND C-HA-RAS ONCOGENE EXPRESSION BY CELL-SHAPE
    FARRELL, RE
    GREENE, JJ
    JOURNAL OF CELLULAR PHYSIOLOGY, 1992, 153 (02) : 429 - 435
  • [25] Rapid emergence of mammary preneoplastic and malignant lesions in human c-Ha-ras proto-oncogene transgenic rats: Possible application for screening of chemopreventive agents
    Matsuoka, Y
    Fukamachi, K
    Hamaguchi, T
    Toriyama-Baba, H
    Kawaguchi, H
    Kusunoki, M
    Yoshida, H
    Tsuda, H
    TOXICOLOGIC PATHOLOGY, 2003, 31 (06) : 632 - 637
  • [26] EXPRESSION OF C-HA-RAS ONCOGENE AND CORRELATION WITH TUMORIGENICITY IN HUMAN HYBRID-CELLS
    GEISER, AG
    STANBRIDGE, EJ
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1986, : 149 - 149
  • [27] Lack of effect of human c-Ha-ras proto-oncogene overexpression on prostate carcinogenesis in probasin/SV40 T antigen transgenic rats
    Hokaiwado, N
    Asamoto, M
    Cho, YM
    Tsuda, H
    Shirai, T
    CANCER SCIENCE, 2003, 94 (12) : 1042 - 1045
  • [28] Mammary carcinomas induced in human c-Ha-ras proto-oncogene transgenic rats are estrogen-independent, but responsive to d-limonene treatment
    Asamoto, M
    Ota, T
    Toriyama-Baba, H
    Hokaiwado, N
    Naito, A
    Tsuda, H
    JAPANESE JOURNAL OF CANCER RESEARCH, 2002, 93 (01): : 32 - 35
  • [29] ACTIVATING MUTATIONS IN C-HA-RAS-1 PROTO-ONCOGENE PRODUCED BY ULTIMATE CARCINOGENS AND BY DEPURINATION
    PHILLIPS, DH
    VOUSDEN, KH
    BOS, H
    MARSHALL, CJ
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1985, 26 (MAR): : 61 - 61
  • [30] ANALYSIS OF THE METHYLATION PATTERN OF C-HA-RAS ONCOGENE IN HUMAN PROSTATIC-CANCER
    MENEGAZZI, M
    SCARPA, A
    LIBONATI, M
    ITALIAN JOURNAL OF BIOCHEMISTRY, 1988, 37 (02): : 104 - 110